Infographic summarising an editorial on the gap between CKD guideline recommendations and actual prescribing practice in India.

Read my new editorial in the @indianjnephrol
on how we fall on the hurdle of implementing high-value, guideline-directed therapies to our patients with chronic diseases
t.co/Tqy7fp9N1R

ISN-@kdigo.org joint session: "Implementing Updated KDIGO AKI/AKD Guidelines Worldwide"
🗓️ March 29
🕤 9:25 a.m.
📍 501-502
@vjha.bsky.social #ISNWCN

𝗜𝗦𝗡 𝗔𝘄𝗮𝗿𝗱𝘀:
🇮🇳 @vjha.bsky.social , winner of the 𝗝𝗲𝗮𝗻 𝗛𝗮𝗺𝗯𝘂𝗿𝗴𝗲𝗿 𝗔𝘄𝗮𝗿𝗱
🇺🇸 John Kellum, winner of the 𝗕𝘆𝘄𝗮𝘁𝗲𝗿𝘀 𝗔𝘄𝗮𝗿𝗱
🇳🇱 Ron Gansevoort, winner of the 𝗟𝗶𝗹𝗹𝗶𝗮𝗻 𝗝𝗲𝗮𝗻 𝗞𝗮𝗽𝗹𝗮𝗻 𝗣𝗿𝗶𝘇𝗲 𝗳𝗼𝗿 𝗣𝗞𝗗
#ThisIsISN #ISNAwards #ISNWCN

🎙️ Check out the latest Global Kidney Care Podcast!

Winston Fung leads a discussion on how climate change is shaping kidney health 🌎 with Prof. @vjha.bsky.social, Maryvonne Hourmant, @sfndt.bsky.social Past president, and Letizia De Chiara.

globalkidneycarepodcast.transistor.fm/episodes/sea...

Our Nutrition team took India’s voices to the global stage at 23rd IUNS International Congress of Nutrition in Paris. With 7 presentations, they showcased Indigenous food systems, dietary diversity, child feeding practices, food procurement, Indian adaptation of the Mediterranean diet & more. [1/2]

🏅 Prof. Vivekanand Jha @vjha.bsky.social‬ (India), winner of the Jean Hamburger Award lite.spr.ly/6000KvmY

First randomization in India for EASi-KIDNEY!🎉🥳
Big thanks to and the PGIMER team for leading the start, and to all our partner sites for their commitment and support.

Also to the fantastic colleagues at @georgeinstitute.bsky.social and Oxford NDPH

www.easikidney.org

NOACs offer a practical solution for PMN patients at high risk of thrombosis—less monitoring, fewer clinic visits, and good safety profile, even in low-resource settings. More research needed, but early results are encouraging! #KidneyHealth #Anticoagulation

New study: NOACs like apixaban safe & effective for short-term prevention of blood clots in primary membranous nephropathy patients with low albumin—no VTEs, low bleeding risk. Promising alternative to warfarin! #Nephrology #VTE #PatientCare t.co/mSt3nhKMvm @isn-india.bsky.social

Understand the journey from preclinical primate studies to human deceased donor (decedent) and living recipient transplants, and the ethical, social, regulatory, and practical implications of this technology, including its potential for scalability, cost, relevance to children.

Listen to Dr Vasistha Tatapudi of from focusing on the use of pig kidneys in humans - the rationale, immunological challenges, and genetic modifications involved in overcoming hyperacute rejection. t.co/Htzs11a711

Nice case and good discussion on how to interpret clinical clues

Case Presentations in Nephrology - An Indian Society of Nephrology Initiative
YouTube Recording 👉 m.youtube.com/watch?v=0yuO...
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh @vjha.bsky.social
Presented by - Dr Jugal Mehta (Mumbai)

Cholecalciferol supplementation significantly improved vascular function (flow-mediated dilation) in CKD patients,

Changes in immune and vascular function were not directly linked. Findings support vitamin D’s role in immune and vascular health in CKD.

Secondary analysis of RCT of High-dose cholecalciferol (vitamin D3) in non-diabetic #CKD patients. #Vit D
➡️ shifted immune balance toward anti-inflammatory TH2 cells,
➡️ ⬇️ pro-inflammatory cytokines, ⬆️ vitD-responsive gene expression
➡️ showing direct immune modulation benefits CKD. #Immunology

Frontiers | Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease

Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease
frontiersin.org/journals/imm...
@vjha.bsky.social

Congratulations to Dr Jha and the team! Collaboration and data sharing is the way forward! 🇮🇳🏖️

➡️ establishes platform for studying disease course, treatment patterns, and outcomes of GNs in India
➡️ with consent for contact regarding clinical trials and biobanking, offers recruitment potential 4 studies investigating emerging therapies
➡️ Collaboration with established international registries

Decoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE Registry Glomerular diseases are a leading cause of kidney disease worldwide, especially in low-and middle-income countries. At the global level, collaborative initiatives have been started to provide informat...

Presenting #iTANGIBLE - a nationwide Indian collaborative effort to study common primary glomerular diseases in India.

➡️ The first such cohort in the developing (majority) world
➡️ Will help understand disease phenotypes in the Indian context

Funded by #ICMR

www.kireports.org/article/S246...

World Kidney Day logo and this year's campaign, Are your Kidneys OK campaign logo

Happy 20th anniversary #WorldKidneyDay 🎉
Two decades of successful awareness campaigns!

On this year, WKD invites you to ask yourself #AreYourKidneysOK? Knowing the answer to this question can detect signs of early kidney disease and prevent it from worsening.

Remembering Bill Couser who we lost recently on this #WKD for his huge contributions to conceiving this initiative that has made such a difference to kidney health awareness around the world @theisn.org

www.kidney-international.org/article/S008...

🌎Are your kidneys OK? ¿Tus riñones están bien? Vos reins vont bien? هل كليتيك بخير؟ ; आपकी किडनी ठीक है? Os seus rins estão bem? @theisn.org @drpriyajohn.bsky.social @nephromythri.bsky.social @sabinekaram.bsky.social

#WorldKidneyDay #KidneyHealthForAll #NephSky #BlueSky

#WorldKidneyDay Rally in #Bangladesh.

Thanks @roy-chaudhury.bsky.social and tons of colleagues from all around the world for making the Congress such a success - #WCN was really special with its theme of equity, sustainability and accountability

Congratulations Vivek on the broad swathe of holistic science presented at WCN in New Delhi. It was an outstanding meeting!
@vjha.bsky.social @charumalik.bsky.social @asnkidney.bsky.social @uncdeptmedicine.bsky.social

@vjha.bsky.social welcoming the audience to India and #ISNWCN

"Decoding Glomerulonephritis: Baseline Profiles and Insights from the I-TANGIBLE Registry" by Kavita Yadav, @vjha.bsky.social et al.

🔗 Download the visual abstract by @sayalibthakare.bsky.social www.theisn.org/wcn/w... #ISNWCN

First steps in efforts to characterise the burden of CKDu across different regions. Fantastic work led by Charlotte in collaboration with so many brilliant investigators from around the world.

If we understand where it is, maybe we can understand what it is.

with @vjha.bsky.social and others

The @natureportfolio.bsky.social Access to Dialysis in Low and Middle-Income Countries Commission will explore Thailand’s experiences with changing its dialysis coverage policy, offering lessons for other countries with universal health coverage systems

@theisn.org @who.int @hitap.bsky.social

🩺 Universal Health Coverage in Action

Thailand’s PD-first policy proved dialysis can be affordable in LMICs, but its reversal raises questions about equity and sustainability. Can lessons from Thailand guide better UHC policies globally? #KidneyCare #SustainableHealthcare